Realisation of mammography screening in Khanty-Mansiysk Autonomous State – Yugra
https://doi.org/10.17650/1994-4098-2020-16-3-32-36
Abstract
Objective: to perform a retrospective analysis of the quality of mammography screening in Khanty-Mansiysk State Region – Yugra from its beginning to 2018 inclusive.
Materials and methods. During this investigation a throughout analysis of epidemiological indicators (breast cancer mortality and morbidity), quality indicators (coverage of the target population, cancer detection in general and early detection, sensitivity and morbidity) and mammographic screening performance indicators (projected and observed morbidity and mortality) was carried out.
Results and conclusions. During this period, 572,348 women were screened, 9.7 % of whom were recommended for further screening. The coverage of the target population for one round was 33 %. Screening test sensitivity for the specified period was 80 %. The observed number of women with newly detected breast cancer cases of stage I in 2018 made 42 % (53 cases) higher in comparison with expected numbers, and in stage T2+ it made 21 % (62 cases) less. The observed number of deaths in 2018 was 23.7 % lower than expected. The above-mentioned demonstrates once again that mammography screening in Khanty-Mansiysk State Region – Yugra has led to the improvement of early diagnosis of breast cancer. This, in turn, leads to a steady decline in breast cancer mortality among women over 40 years of age.
About the Authors
Ju. A. Belaya
District Clinical Hospital
Russian Federation
40 Kalinina St., Khanty-Mansiysk 628002
Russian Federation
40 Kalinina St., Khanty-Mansiysk 628002
N. A. Zakharova
St. Albans City Hospital, West Hertfordshire Hospitals Trust
United Kingdom
Waverley Road, St. Albans, Hertfordshire AL3 5PN
United Kingdom
Waverley Road, St. Albans, Hertfordshire AL3 5PN
A. R. Brentnall
Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London
United Kingdom
Garrod Build., Turner St., Whitechapel, London E1 2AD
United Kingdom
Garrod Build., Turner St., Whitechapel, London E1 2AD
References
1. Duffy S.W., Vulkan D., Cuckle H. et al. Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial. Lancet Oncol 2020;9(21):1165–72. DOI: 10.1016/S1470-2045(20)30398-3.
2. Miller A.B. Final results of the UK Age trial on breast cancer screening age. Lancet Oncol 2020;9(21):1125–6. DOI: 10.1016/S1470-2045(20)30428-9.
3. Wise J. Breast cancer: study claiming that screening women in their 40s saves lives “found the opposite”, say critics. BMJ 2020;370:m3191. DOI: 10.1136/bmj.m3191.
4. Oeffinger K.C., Fontham E.T., Etzioni R. et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 2015;314:1599–614. DOI: 10.1001/jama.2015.12783.
5. Siu A.L. Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2016;164:279–96. DOI: 10.7326/M15-2886.
6. Schünemann H.J., Lerda D., Quinn C. et al. Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines. Ann Intern Med 2020;172:46–56. DOI: 10.7326/M19-2125.
7. Checka C.M., Chun J.E., Schnabel F.R. et al. The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 2012;198:W292–5. DOI: 10.2214/AJR.10.6049.
8. Tabár L., Chen H.H., Fagerberg G. et al. Recent results from the Swedish TwoCounty trial: the effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst Monogr 1997;22:43–7. DOI: 10.1093/jncimono/1997.22.43.
9. Moser K., Sellars S., Wheaton M. et al. Extending the age range for breast screening in England: pilot study to assess the feasibility and acceptability of randomization. J Med Screen 2011;18:96–102.
10. Moss S.M., Wale C., Smith R. et al. Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years’ follow-up: a randomised controlled trial. Lancet Oncol 2015;16:1123–32.
11. Zakharova N.A., Semiglazov V.F., Duffy S.W. Breast cancer screening: problems and solutions. Moscow: GEOTAR-Media, 2011. 175 p. (In Russ.).
12. Belaya Yu.A., Zakharova N.A. Review of the realization of the breast cancer screening during 7 years in Khanty-Mansiysk autonomous region – Yugra. Opukholi zhenskoy reproduktivnoy systemy = Tumors of female reproductive system 2016:(2);18–21. (In Russ.). DOI: 10.17650/1994-4098-2016-12-2-18-21.
13. Zakharova N.A., Kotlyarov E.V., Gromut I.P. Assesment of the quality of mammographic screening and analysis of breast cancer risk factors in Regional Clinical Hospital of Khanty-Mansiysk. Uralskiy meditsinskiy zhurnal = Medical Journal of Ural 2010;12(77):55–9. (In Russ.).
14. Zakharova N.A., Belaya Yu.A., Brentnall A.R. Review of the realization of the breast cancer screening during 10 years in Khanty-Mansiysk autonomous region – Yugra. Uralskiy meditsinskiy zhurnal = Medical Journal of Ural 2018;(5):41–6. (In Russ.). DOI: 10.25694/URMJ.2018.04.070.
15. Zakharova N.A. Role of the mammographic density as an additional risk factor of the breast cancer development and its negative influence on the screening effectivity. Zlokachestvennye opukholi = Cancers 2019;9(3-S1):63. (In Russ.).
Review
For citations:
Belaya J.A., Zakharova N.A., Brentnall A.R. Realisation of mammography screening in Khanty-Mansiysk Autonomous State – Yugra. Tumors of female reproductive system. 2020;16(3):32-36. (In Russ.) https://doi.org/10.17650/1994-4098-2020-16-3-32-36
Views:
894
Email this article 